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ABSTRACT
Purpose: Both nutritional status and echocardiographic parameters are associated with the risk of atrial 
fibrillation (AF). The aim of this study was to determine the relationships between parameters of transtho-
racic echocardiography and nutritional status assessment as risk factors for AF. 
Methods: This cross-sectional study considered 120 consecutive patients hospitalized due to AF and 240 
inpatients admitted due to exacerbation of cardiovascular conditions. Echocardiographic parameters and 
parameters of nutritional status were determined for each patient. 
Results: Patients in the lowest body mass index (BMI) quartile and without visceral adiposity had the 
lowest standard echocardiographic parameters; however, the majority of these differences disappeared 
after the parameters were indexed to BSA. In logistic regression analysis, echocardiographic parameters 
were associated with slightly higher or similar AF risk comparing with parameters of nutritional status 
assessment. When the comparison was made in relation to cut-off values obtained in ROC analysis, then 
having a visceral adipose tissue (VAT) score ≥ 12 was associated with a lower increase in AF risk (odds 
ratio [OR]; 95% confidence interval [CI]: 3.09; 1.85–5.15) than the risk increase associated with e.g. left 
atrium diameter greater than 45mm ([OR; 95% CI] 10.483; 6.308–17.421).
Conclusions: The unitary values of echocardiographic and body composition parameters only slightly 
differed in relation to the risk of AF occurrence, however, the use of cut-off values significantly increases 
an impact of echocardiography on the prediction of AF.  The U-shaped relationships between a patient’s 
nutritional status and AF occurrence cannot be explained by the effect of body mass on cardiac structure 
and size. 
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Introduction
Disturbances in nutritional status and atrial fibrillation 
(AF) are significant current health problems. Obesity is 
one of the evidenced risk factors for AF [1, 2], although 
diabetes mellitus, hypertension, obstructive sleep ap-
nea, enlargement of the left atrium, and cardiac failure 
also influence the risk of atrial arrhythmia [3, 4]. How-
ever, the importance of undernutrition as a risk factor 
for AF is understudied due to the exclusion of patients 
with a body mass index (BMI) < 18.5 kg/m2 from the 
majority of studies on associations between patients’ 
nutritional status and the risk of various cardiovascular 
conditions [1]. 
Echocardiography is a basic diagnostic tool for 
patients with cardiovascular disorders. In patients with 
AF, the tool helps to identify the cause of arrhythmia 
(e.g. valvular AF, nonvalvular AF, cardiomyopathy), to 
localize the site of arrhythmia complication (e.g. the 
presence of thrombus in the left atrial appendage), to 
predict the risk of arrhythmia recurrence (e.g. left atrium 
diameter), and to treat patients with arrhythmia (e.g. 
during left atrium appendage closure) [5]. It seems 
reasonable that individuals with greater height and body 
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size have higher echocardiographic parameter values 
than people who are smaller [6]. However, reductions 
in body mass and changes in body composition after 
bariatric surgery (unrelated to changes in patients’ 
height) led to a reduction in values of echocardiographic 
parameters of the left ventricle [7–9]. Moreover, the 
associations between heart dimensions and nutritional 
status are complicated by the distribution of adiposity, 
which an example is the relationship between epicardial 
adipose tissue (EAT) and left atrial size that was found to 
be positive for patients with paroxysmal AF and negative 
for patients with permanent AF [10]. Such effect of fat 
tissue on heart remodelling and risk of arrhythmia is 
explained by its paracrine, endocrine and proinflam-
matory properties [10–12]. These data suggest that the 
association between heart morphology and function 
and patient nutritional status may be more complicated 
than simply a relationship with body size or body surface 
area (BSA). As a result of left ventricle enlargement, 
hypertrophy, diastolic and systolic dysfunction, as well 
as an increase in left atrial diameter, area and volume 
is associated with a rise in patient morbidity and mor-
tality [13], and risk of AF occurrence and recurrence 
after cardioversion [5], we tried to answer the following 
questions: (a) Are there any relationships between the 
parameters of transthoracic echocardiography and nu-
tritional status assessment (e.g. BMI)? (b) Are there any 
relationships between the parameters of transthoracic 
echocardiography and adiposity distribution? and (c) 
What is the strength of the relationship between the 
parameters of echocardiography and nutritional status 
assessment and the risk of AF occurrence?  
Materials and methods
Patients
This cross-sectional study considered 120 con-
secutive patients hospitalized due to nonvalvular AF 
and 240 inpatients admitted to hospital due to exac-
erbation of cardiovascular conditions (control group). 
The exclusion criteria were: history or clinical signs of 
inflammatory processes or neoplasm or valvular heart 
disease; a significant decrease in body weight during 
the three months prior to the current hospitalization (i.e. 
a quotient of [100% × (usual weight — actual weight)/ 
/usual body weight] being greater than 5%); the history 
of disorders affecting food intake or absorption; lack of 
informed consent for participation in the study; and an 
implanted cardioverter or cardiostimulator (a contra-
indication for bioelectrical impedance analysis, BIA). 
Patients were recruited to the study between July 01, 
2015, and December 31, 2016. 
During the first day of hospitalization, a medical 
history was obtained from each of the inpatients en-
rolled in the study and a physical examination was per-
formed, including the measurement of anthropometric 
parameters of nutritional status. An electrocardiogram 
(ECG) and transthoracic echocardiography were also 
performed for each patient. 
Biochemical determinations
Blood samples for routine determinations, including 
NH(2)-terminal pro-brain natriuretic peptide (NT-proB-
NP)  were taken from the ulnar vein of each patient 
between 7 am and 8 am on the day of admission while 
the patients were in a fasting state.
Parameters of nutritional status assessment
A nutritional status assessment was performed for 
all the study participants. The following parameters were 
measured: height (cm), body weight (kg), waist circumfer-
ence (WC, cm), hip circumference (HC, cm), mid-arm cir-
cumference (MAC, cm), as well as the handgrip strength of 
the predominant hand. All circumferences were measured 
using tape, skinfolds with a Harpenden MG-4800 skinfold 
manual caliper (produced by BATY, UK), and handgrip 
strength using an electronic dynamometer (manufactured 
by Kern, Germany). Body composition was determined 
using BIA and a TANITA BC 420 MA device (TANITA 
Corporation, Japan). The following BIA parameters were 
analyzed: fat mass (FM; % and kg), visceral adipose tis-
sue (VAT) level (in the range 1-59, a level > 26 showing 
abdominal adiposity), fat-free mass (FFM, kg), predicted 
muscle mass (PMM, kg), which assesses both smooth 
and skeletal muscle mass, skeletal muscle mass (SMM, 
expressed in %, kg), bone mass (BM, kg), total body 
water (TBW; and kg), basal metabolic rate (BMR, kcal), 
and metabolic age (MA, years). 
The following secondary parameters were calculat-
ed based on the above-mentioned indices: 
 — BMI (kg/m2) — calculated as a quotient of body 
mass expressed in kg and squared height ex-
pressed in m; 
 — an “ideal weight” — calculated according to 
the Lorentz formula: for female patients, ideal 
weight = [height (cm) – 100] – {[height (cm) – 150]/2}; 
and for male patients, ideal weight = [height (cm) 
– 100] – {[height (cm) – 150]/4};
 — the quotient of actual (current) to ideal body 
mass × 100%; “body mass deficit” was diagnosed 
when this quotient value was below 100%; 
 — waist-to-hip ratio (WHR) — calculated as the quo-
tient of WC and HC; the cut-off values for diagnosis 
of abdominal adiposity were 0.8 for females and 
1.0 for males; 
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 — waist-to-height ratio (WHtR) — calculated as the 
quotient of WC to height (cm) × 100; the established 
cut-off values of this index for diagnosis of abdomi-
nal adiposity (the central or android type of obesity) 
were 0.58 for females and 0.63 for males [14–16], 
 — skeletal muscle mass index (SMI) — calculated as 
a quotient of skeletal muscle mass obtained in BIA 
expressed in kg and squared height expressed in m. 
Parameters of transthoracic echocardiography
Echocardiography was performed at admission by 
the same, experienced cardiologist, using a transtho-
racic ultrasound device (Aplio, TOSHIBA) and a 10 MHz 
radial probe. The following echocardiographic parame-
ters concerning both left ventricle (LV) and left atrium 
(LA) were determined: interventricular septum thickness 
(IVST, mm) at end-diastole; posterior wall thickness 
(PWT, mm) at end-diastole; left ventricular end-diastolic 
dimension (LVEDD, mm); mean wall thickness (MWT, 
mm); relative wall thickness (RWT, mm); left ventricular 
mass (LVM, g); left ventricular mass indexed to body 
surface area (LVM/BSA, g/m2); left ventricular ejection 
fraction (LVEF, %); left atrium diameter (LAD, mm); 
left atrium diameter indexed to body surface area 
(LAD/BSA, mm/m2); left atrium area (LAA, cm2) in apical 
four- and two-chamber views (LAA4 and LAA2); left atri-
um area in apical four- and two-chamber views indexed 
to body surface area (LAA4/BSA, LAA2/BSA, cm2/ m2); 
left atrium volume in apical four- and two-chamber 
views (LAV4 and LAV2, ml); and left atrium volume in 
apical four- and two-chamber views indexed to body 
surface area (LAV4/BSA and LAV2/BSA, ml/m2). A left 
atrial volume was assessed using the biplane method. 
Left ventricular mass was calculated using the following 
formula: 
LVM (g) = 0.8 × {1.04 × ([LVEDD + IVST + PWT]3  
- LVEDD3)} + 0.6
Body surface area was calculated using the follow-
ing formula: 
BSA (m2) = 0,01666667 × height0.5 × body mass0.5
Bioethics
The investigation was conducted in compliance with 
the Declaration of Helsinki for medical research, after 
receiving permission from local Bioethical Committee 
No. 389/2015. Each patient gave written consent to 
participate in the study. 
Statistics
Statistical analysis was conducted using a licensed 
version of statistical software STATISTICA version 
13.1 (a data analysis software system) developed by 
StatSoft, Inc. (2017). The statistical significance level 
was set at a p-value < 0.05. The normal distribution 
of the study variables was checked using the Shap-
iro-Wilk test. The results were mainly presented as the 
mean ± standard deviation, or n, %. The statistical 
significance of differences between groups was verified 
using the Student’s t-test, the Mann-Whitney U test and 
the Chi2 test. Logistic regression analysis with a qua-
si-Newton estimation model was used to determine the 
odds ratio (OR) and 95% confidence interval (CI) of the 
one unit of the continuous (quantity) variables in relation 
to the risk of atrial fibrillation occurrence. Cut-off values 
for respective parameters of echocardiography and 
parameters of nutritional status assessment that have 
a predictive value for the risk of the atrial fibrillation were 
determined for maximal Youden indices by plotting the 
receiver operator curves (ROC). All the patients were 
then classified into two groups based on those cut-off 
values. For such obtained qualitative variables, using 
free internet calculator (https://www.medcalc.org/calc/ 
odds_ratio.php), the OR was determined as the risk 
that atrial fibrillation would occur with an associated 
higher value of a respective variable (e.g. LAD ≥ 45mm 
or LVED ≥ 48mm), compared to the chance of the atrial 
fibrillation occurring in patients with its lower value (e.g. 
LAD < 45mm or LVED < 48mm). 
Results
Clinical characteristics
While individuals with a BMI value in the lowest 
quartile were similar to patients from the higher quartiles 
in relation to the clinical variables, the lowest quartile 
group had significantly lower values for the majority of 
the estimated crude echocardiographic parameters 
(Tab. 1). However, when echocardiographic parameters 
were indexed to body surface area, these significant 
differences either disappeared or were less apparent. 
After adjustment for BSA, the only statistically signifi-
cant difference between the patient groups divided in 
relation to BMI quartiles concerned the left atrium diam-
eter, which was higher in patients from the lowest BMI 
quartile compared to the other patient groups (Tab. 1). 
Associations between parameters of abdominal 
adiposity and echocardiography
Next, we compared the values of the echocardio-
graphic parameters in a split analysis performed in 
relation to generally accepted cut-off criteria for WHR 
(data not presented in detail) and WHtR (Tab. 2) for 
abdominal adiposity, as well as in relation to the median 
VAT score in BIA, which was 12 (data not presented in 
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Table 1. Clinical and echocardiographic parameters in relation to quartiles of BMI
Parameter BMI < 24.42
(n = 90)
24.42 ≤ BMI  
< 27.66
(n = 90)





Age (years) 72.20 ± 9.37 70.43 ± 9.10 68.55 ± 8.99 69.10 ± 8.98
Male gender (n, %) 40 (44.44%) 42 (46.67%) 58 (64.44%) 39 (43.33%) #










Hypertension (n, %) 65 (72.22%) 84 (93.33%)* 78 (86.67%) 83 (92.22%)*
Diabetes mellitus (n, %) 22 (24.44%) 35 (38.89%) * 40 (44.44%)* 44 (48.89%)*
Past myocardial infarction (n, %) 11 (12.22%) 19 (21.11%) 16 (17.78%) 20 (22.22%)
CABG (n, %) 5 (5.56%) 7 (7.78%) 6 (6.67%) 12 (13.33%)
PCI (n, %) 16 (17.78%) 15 (16.67%) 11 (12.22%) 15 (16.67%)
Atrial fibrillation (n, %) 20 (22.22%) 25 (27.78%) 32 (35.56%) 45 (50%) *#
NYHA class (III-IV, n, %) 10 (11.11%) 6 (6.67%) 7 (7.78%) 23 (25.56%) *+#
NT-proBNP (pg/ml) 1800.84 ± 3254.82 972.79 ± 3254.82* 846.72 ± 1362.90* 1542.17 ± 2426.32#
Interventricular septum thickness  
at end-diastole (mm)
10.53 ± 1.69 11.06 ± 1.86* 11.79 ± 1.64*+ 12.5 ± 1.84*+#
Posterior wall thickness at end-diastole 
(mm)
10.18 ± 1.88 10.64 ± 1.84 11.33 ± 1.64*+ 12.0 ± 1.56*+#
Left ventricular end-diastolic dimension 
(mm)
47.02 ± 6.10 47.41 ± 8.71 49.24 ± 8.79 49.8 ± 8.26*
Mean wall thickness (mm) 10.35 ± 1.74 10.85 ± 1.81 11.56 ± 1.59*+ 12.2 ± 1.62*+#
Relative wall thickness (mm) 0.45 ± 0.09 0.54 ± 0.58 0.57 ± 0.73 0.5 ± 0.40*
Left ventricular mass (g) 180.91 ± 59.65 197.18 ± 74.45 227.35 ± 70.90*+ 249.30 ± 72.50 *+#
Left ventricular mass indexed to BSA (g/
m2)
109.07 ± 33.33 107.22 ± 36.45 113.67 ± 32.59 117.42 ± 31.19+
Left ventricular ejection fraction (%) 58.34 ± 11.98 57.66 ± 10.19 57.15 ± 10.76 55.2 ± 10.83
Left atrium diameter (mm) 39.11 ± 7.11 41.09 ± 5.44* 43.27 ± 6.77*+ 46.1 ± 7.20*+#
Left atrium diameter indexed to BSA 
(mm/m2)
23.78 ± 4.56 22.57 ± 3.05* 21.78 ± 3.48* 21.9 ± 3.74*
Left atrium area in apical four-chamber 
view (cm2)
19.86 ± 6.23 20.41 ± 5.26 23.83 ± 10.58*+ 27.50 ± 17.66*+
Left atrium area in apical two-chamber view 
(cm2)
21.41 ± 5.21 21.91 ± 5.63 23.29 ± 5.58* 26.30 ± 5.31+#
Left atrium area in apical four-chamber 
view indexed to BSA (cm2/m2)
12.07 ± 3.79 11.18 ± 2.77 11.95 ± 4.97 13.0 ± 7.90+
Left atrium area in apical two-chamber view 
indexed to BSA (cm2/m2)
13.01 ± 3.91 12.01 ± 3.01 11.72 ± 2.76* 12.50 ± 2.79
Left atrium volume in apical four-chamber 
view (ml)
71.31 ± 36.28 73.00 ± 29.58 84.48 ± 28.15*+ 99.7 ± 30.32*+#
Left atrium volume in apical two-chamber 
view (ml)
74.43 ± 36.16 77.43 ± 31.86 86.89 ± 30.46*+ 102.6 ± 30.43*+#
Left atrium volume in apical four-chamber 
view indexed to BSA (ml/m2)
43.21 ± 21.51 39.85 ± 15.36 42.46 ± 14.30 47.2 ± 14.37+#
Left atrium volume in apical two-chamber 
view indexed to BSA (ml/m2)
45.15 ± 21.82 42.31 ± 16.74 43.58 ± 15.07 48.7 ± 15.15+#
AF — atrial fibrillation; BMI — body mass index; BSA — body surface area; CABG — coronary artery bypass graft; NT-proBNP — NH(2)-terminal 
pro-brain natriuretic peptide; NYHA — the stage of heart failure according to the New York Heart Association classification; PCI — percutaneous 
coronary intervention. Statistical significance of difference: *p < 0.05 between columns 1 and 2, 3, 4; + = p < 0.05 between columns 2 and 3, 4; 
#p < 0.05 between columns 3 and 4
Marzena Anaszewicz, Jacek Budzyński, Body composition, echocardiography and atrial fibrillation
171www.journals.viamedica.pl/medical_research_journal
Table 2. Echocardiographic parameters in patients in relation to type of adiposity diagnosed in relation to standard 
gender-related cut-off values of WHtR
Parameter WHtR ≥ 0.58/0.63
(n = 200)
WHtR < 0.58/0.63
 (n = 160)
p
Interventricular septum thickness at end-diastole (mm) 11.83 ± 1.94 10.99 ± 1.74 < 0.001
Posterior wall thickness at end-diastole (mm) 11.41 ± 1.79 10.57 ± 1.85 < 0.001
Left ventricular end-diastolic dimension (mm) 48.82 ± 7.70 47.81 ± 8.54 0.240
Mean wall thickness (mm) 11.62 ± 1.80 10.78 ± 1.76 < 0.001
Relative wall thickness (mm) 0.52 ± 0.41 0.53 ± 0.61 0.86
Left ventricular mass (g) 225.47 ± 72.28 199.09 ± 74.33 < 0.001
Left ventricular mass indexed to BSA (g/m2) 114.88 ± 32.43 108.05 ± 34.63 0.055
Left ventricular ejection fraction (%) 56.04 ± 11.10 58.40 ± 10.67 0.043
Left atrium diameter (mm) 43.66 ± 7.29 40.74 ± 6.62 < 0.001
Left atrium diameter indexed to BSA (mm/m2) 22.51 ± 3.80 22.46 ± 3.86 0.914
Left atrium area in apical four-chamber view (cm2) 24.67 ± 14.21 20.65 ± 5.77 < 0.001
Left atrium area in apical two-chamber view (cm2) 24.16 ± 5.82 22.09 ± 6.08 0.0012
Left atrium area in apical four-chamber view indexed to BSA (cm2/m2) 12.58 ± 6.38 11.36 ± 3.19 0.028
Left atrium area in apical two-chamber view indexed to BSA (cm2/m2) 12.35 ± 3.03 12.18 ± 3.49 0.627
Left atrium volume in apical four-chamber view (ml) 88.07 ± 32.01 74.57 ± 33.02 < 0.001
Left atrium volume in apical two-chamber view (ml) 91.11 ± 32.31 78.23 ± 34.79 < 0.001
Left atrium volume in apical four-chamber view indexed to BSA (ml/m2) 44.97 ± 15.54 40.87 ± 18.01 0.021
Left atrium volume in apical two-chamber view indexed to BSA (ml/m2) 46.31 ± 16.14 42.67 ± 19.46 0.053
BSA — body surface area; WHtR — waist-to-height ratio, with 0.58  as the cut-off value for abdominal adiposity in women and 0.63 as the cut-off 
value for men
detail). We found that patients with abdominal adipos-
ity had significantly greater values for the majority of 
crude echocardiographic parameters analyzed, with 
the exception of LVEF, which was significantly lower. 
However, after indexing the echocardiographic parame-
ters by BSA, the only statistically significant differences 
[in the split analysis] concerned LAA4 and LAV4 in 
relation to WHtR value and LAD and LAV4 in relation 
to VAT score.  On the other hand, patients with a body 
weight deficit (n = 33; 9.17%) had lower values for the 
echocardiographic parameters analyzed, and the statis-
tical significance of these differences disappeared after 
indexing to BSA (data not presented in detail). However, 
patients with body weight deficit had significantly higher 
blood NT-proBNP concentration than their counterparts 
(2707.09 ± 4458.03 vs. 1143.50 ± 2044.90 pg/ml; 
p < 0.001). 
Spearman’s correlation between 
echocardiographic parameters and BIA
In order to determine the strength of the relation-
ships between the parameters of nutritional status 
assessment and the echocardiographic indices, we 
also performed a regression analysis using Spear-
man’s correlations (Tab. 3). The strongest relation-
ships concerned such crude echocardiographic pa-
rameters as LVM, LVEDD, LAD, LAA, LAV, IVST, and 
PWT. The relationships showed that BIA parameters 
of nutritional status assessment (body composition) 
explained 2–27% of the variance in echocardiographic 
parameters. However, the power of these associations 
decreased by 36–73% when they were indexed to BSA 
(Tab. 3). Similar observations were obtained both for 
the whole study group and separately for patients with 
AF and in the control group. 
Risk of AF occurrence associated with 
echocardiographic and nutritional parameters 
The lack of statistically significant relationships be-
tween parameters of adipose tissue distribution and the 
values of the echocardiographic parameters indexed to 
BSA might suggest that cardiac ultrasound morphology 
in our patients depended not on the patients’ nutritional 
status, but on body size or individual, non-nutritional 
factors determining morphological and/or electrical 
cardiac remodelling. This hypothesis might run counter 
to, for example, evidenced data linking obesity with 
the risk of AF [1, 2]. Therefore, we performed analysis 
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using logistic regression in order to determine the 
power of the relationships between nutritional status 
assessment and the values of the echocardiographic 
parameters and the risk of AF diagnosis (Tab. 4). When 
continuous values of respective parameters were taken 
into account in logistic regression analysis, it occurred 
that parameters of echocardiography (e.g. LVED, LAD, 
LAD/BSA, LAA4/BSA, and LAA2/BSA) are linked only 
slightly less or similar to the risk of AF [expressed as 
OR value] than the parameters of nutritional status 
assessment (Table 4). However, when OR values were 
calculated in relation to cut-off values obtained in ROC 
analysis, the significantly higher OR values referred to 
echocardiographic than nutritional parameters (Tab. 4). 
In other words, for example, the risk of AF was much 
considerably increased in patients with left atrium di-
ameter ≥ 45mm than those with obesity diagnosed on 
the base of the excess of FM found in BIA (FM>35% 
for females and > 25% for males) and abdominal dis-
tribution of adipose tissue (e.g. VAT score ≥ 12). Deficit 
of body mass did not significantly affect the risk of AF 
([OR; 95% CI] 0.572; 0.250-1.305; p = 0.185).
Discussion
In our study, we found relationships between pa-
rameters of body composition and echocardiographic 
parameters (Tab. 1–3). However, indexing heart ul-
trasound parameters to BSA made their associations 
with parameters of nutritional status weaker (Tab. 
3). Indices of body composition analysis explained 
2-27% of crude (unindexed) and 2–8% of the indexed 
echocardiographic parameter values (Tab. 3). We fur-
ther found that parameters of obesity and abdominal 
adiposity compared to parameters of transthoracic 
echocardiography predicted AF risk similarly or only 
little weaker, however, only when they were taken into 
account as continuous variables (Tab. 4). However, 
when we calculated OR variables in relation to cut-off 
values obtained in ROC analysis, the prediction power 
for echocardiography was stronger than for parameters 
of nutritional status assessment. 
The links between obesity and the risk of AF and 
other cardiovascular conditions found in our study have 
been evidenced previously [1, 2, 17]. The evidence for 
the associations mentioned is strengthened through 
a reported favorable effect of weight reduction on the 
risk of AF occurrence [8, 9]. However, the relationships 
between parameters of body composition in BIA and 
parameters of echocardiography and between echo-
cardiographic parameters and undernutrition have 
only been explored in one publication apiece [5]. The 
results of these works corroborate ours (Tab. 1, 3, 4). In 
a study by Mancusi et al. [18], obesity was associated 
with a 6.9 times higher prevalence of LV hypertrophy. In 
research by Huang et al. [5], obese patients had larger 
LAD, LAA, and LAV, both in univariate and multivariate 
analysis. Dibeklioglu et al. [19] showed that obesity in 
children was a risk factor for LV hypertrophy indepen-
dent of hypertension, and Kurisu et al. [20] found an 
influence of BMI on the correlations between LVM and 
ECG indices used in the diagnosis of LV hypertrophy, 
such as the Cornell product and Sokolow-Lyon indices. 
Our results are also consistent with the outcome of 
investigations exploring the effect of visceral adipose tis-
sue distribution on echocardiographic parameters and 
risk of AF (Tab. 2). Yoon et al. [21] reported a significant 
trend in increasing values of LVM/BSA and LAD across 
VAT tertiles. In a study by Chau et al. [22], individuals 
with elevated waist circumference had a twofold higher 
risk of diastolic dysfunction of LV than those without 
central adiposity. In an investigation by Tugcu et al. 
[23], higher WC was significantly associated with higher 
LAV. Using multivariable logistic regression models, 
Son et al. [24] also found significant relationships 
between WC and enlargement of LA and LV and LV 
hypertrophy in healthy male Koreans. Mornar Jelavić et 
al. [16] reported that among patients with acute ST-ele - 
vation myocardial infarction (STEMI) treated with the 
percutaneous coronary intervention (PCI), those with 
abdominal adiposity defined by greater WHR values had 
higher rates of significantly stenosed proximal/middle 
coronary segments, while those with a greater WHtR 
had the highest rates of heart failure and total in-hospital 
complications. Markus et al. [7] used multivariable-ad-
justed linear regression models to analyze the effect 
of changes in body composition measured using BIA 
during a 5 year period on changes in LV geometry and 
function. They found that a 1 kg increase/decrease 
in TBW or FM was associated, respectively, with an 
increase/decrease of 0.89 g or 1.84 g in LVM, and 
an increase in FM was associated with LV concentric 
remodelling and impairment of systolic and diastolic 
function parameters, whereas an increase in FFM was 
associated with LV eccentric remodelling and improved 
systolic and diastolic functional variables. Moreover, 
Şeker et al. [25] reported that epicardial adipose tissue 
thickness was independently associated with abnormal 
LV geometry, hypertrophy, and dysfunction, as well as 
low-grade chronic inflammation. A study by Bairapared-
dy et al. [26] showed that EAT correlated with VAT, so 
we can assume that results by Şeker et al. [25] indirectly 
corroborate our observations. 
In our study, we also found that both general (higher 
FM expressed in kg) and central (greater VAT score) 
adiposity were similar or only a little weaker indicators of 
the risk of AF occurrence as crude and indexed echocar-
diographic parameters (Tab. 4). Only the comparison of 
the predictive power of cut-off values established in ROC 
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Table 4. Risk of atrial fibrillation occurrence associated with clinical, nutritional status and echocardiographic 




OR; 95% CI Parameter of nutritional status assessment OR; 95% CI
Diabetes mellitus 0.779; 0.496-1.223 Age 1.003; 0.980-1.027 
Hypertension 0.760; 0.413-1.399 Gender 0.968; 0.621-1.509 
LVEDD (per mm) 1.062; 1.026-1.100 Weight (per 1 kg kg) 1.027; 1.014-1.041
LVEDD (≥ 48 mm) 28.928; 3.938-212.490 Weight ≥ 90 kg 3.081; 1.898-5.001
LVEF (%) 0.945; 0.926-0.966 Height (per 1 cm) 1.011; 0.989-1.035
LVED ≥ 50% 0.361; 0.198-0.660 BMI (per 1 kg/m2) 1.087; 1.043-1.132
IVST (per mm) 1.157; 0.80-1.299 BMI≥30.27 kg/m2 3.044; 1.913-4.843
IVST (≥ 11mm) 2.108; 1.321-3.363 Actual-to-ideal body mass ratio 1.018; 1.009-1.027
PWT per (mm) 1.267; 1.120-1.432 Waist circumference (per cm) 1.021; 1.004-1.037
LVM (per g) Overabundance of data WC ≥ 108cm 2.391; 1.521-3.759
LVM (≥ 185.90 g) 3.006; 1.846-4.895 Triceps skinfold thickness (mm) 1.021; 0.997-1.045 
LAD (per mm) 1.190; 1.135-2.247 Subscapular skinfold thickness (per mm) 1.005; 0.979-1.031 
LAD ≥ 45 mm 10.483; 6.308-17.421 Abdominal (suprailiac) skinfold thickness (per mm) Overabundance of data
LAA4 (per cm2) 1.113; 1.065-1.162 WHR 1.089; 0.573-2.071 
LAA4 ≥ 21.50 cm2 14.623; 8.089-26.437 WHR for abdominal adiposity 1.24; 0.704-2.186 
LAA2 (per cm2) 1.247; 1.181-1.316 WHtR 1.029; 1.003-1.057
LAA2 ≥ 23.90 cm2 9.405; 5.670-15.598 WHtR for abdominal adiposity 1.519; 0.971-2.376 
LAV4 (per ml) 1.039; 1.029-1.049 FM (per % of body mass) 1.056; 1.028-1.084
LAV4 ≥ 69.50 ml 10.617; 5.661-19.913 Obesity (FM, %) 2.015; 1.231-3.298
LAV2 (per ml) 1.042; 1.032-1.053 FM ≥ 32.60% 2.624; 1.606-4.289
LAV2 ≥ 93.60ml 10.271; 6.182-17.065 FM (per kg) 1.062; 1.038-1.087
LVM/BSA (g/m2) 1.012; 1.005-1.020 FM ≥ 26 kg 4.095; 2.463-6.807
LVM/BSA ≥ 102.77g/m2 2.304; 1.443-3.678 VAT (per 1 score) 1.140; 1.086-1.218
LAD/BSA (mm/m2) 1.196; 1.115-1.283 VAT ≥ 12 (score) 3.091; 1.857-5.153
LAD/BSA ≥ 23mm/m2 3.346; 2.120-5.279 FFM (per kg) 1.023; 1.008-1.044
LAA4/BSA (per cm2/m2) 1.195; 1.104-1.294 FFM ≥ 51.80 kg 1.799; 1.109-2.916
LAA4/BSA≥11.78cm2/m2 7.136; 4.368-11.660 PPM (per kg) 1.024; 1.002-1.046
LAA2/BSA (per cm2/m2) 1.381; 1.255-1.519 PPM ≥ 49.20 kg 1.799; 1.109-2.916
LAA2/BSA ≥ 6.78 cm2/m2 0.512; 0.03-8.27 SMM (per kg) 1.041; 1.004-1.071
LAV4/BSA (per ml/m2) 1.071; 1.051-1.092 SMM ≥ 29.30 kg 1.815; 1.120-2.941
LAV4/BSA ≥ 39.03 ml/m2 6.182; 3.706-10.315 SMM (per 1% of body mass) 0.907; 0.866-0.951
LAV2/BSA (per ml/m2) 1.077; 1.055-1.098 SMM ≥ 52 % 1.050; 0.094-11.717 
LAV2/BSA ≥ 46.25ml/m2 7.707; 4.722-12.582
Data are presented as odds ratio (OR) and 95 confidence interval (95% CI); ns — not significant. OR; 95% CI were calculated using logistic 
regression for quantitative variables, and using the proportional formula for qualitative variables. BMI — body mass index; BSA — body surface 
area; DM — diabetes mellitus; FFM — fat-free mass; FM — fat mass; IVST — interventricular septum thickness at end-diastole; LAA2 — left 
atrium area in apical two-chamber view; LAA2/BSA — left atrium area in apical two-chamber view indexed to body surface area; LAA4 — left 
atrium area in apical four-chamber view; LAA4/BSA — left atrium area in apical four-chamber view indexed to body surface area; LAD — left 
atrium diameter; LAD/BSA — left atrium diameter indexed to body surface area; LAV2 — left atrium volume in apical two-chamber view; LAV2/
BSA — left atrium volume in apical two-chamber view indexed to body surface area; LAV4 — left atrium volume in apical four-chamber view; 
LAV4/BSA — left atrium volume in apical four-chamber view indexed to body surface area; LVEDD — left ventricular end-diastolic dimension; 
LVEF — left ventricular ejection fraction; LVM — left ventricular mass; LVM/BSA — left ventricular mass indexed to body surface area; ns- non-
significant statistically; PMM — predicted muscle mass; PWT — posterior wall thickness at end-diastole; RWT — relative wall thickness; SMM — 
skeletal muscle mass; VAT — visceral adipose tissue; WHR — waist-to-hip ratio; WHtR — waist-to-height ratio
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analysis showed that AF risk was associated significant-
ly stronger with e.g. LVED ≥ 48mm, LAA4 ≥ 21,50cm2 or 
LAD ≥ 45 mm than with FM ≥ 26kg, VAT score ≥ 12, body 
weight ≥ 90kg, and BMI ≥ 30.27 kg/m2.  The associations 
between values of echocardiographic parameters and 
the risk of AF, the outcome of AF treatment and patients 
prognosis are well known, both in relation to the left 
atrium and left ventricle echocardiographic parameters 
[27]. Huang et al. [5] found that a higher risk of AF was 
independently associated with greater LAD and older 
age, but not with BMI and gender. In contrast, Winkle 
et al. [28] reported worse AF ablation outcomes among 
patients with a BMI ≥ 35 kg/m2. Moreover, patients un-
dergoing AF ablation who had a BMI ≥ 40 kg/m2 had 
a higher risk of minor complications. These last obser-
vations may be explained by the above-mentioned data 
concerning the effect of adiposity (FM, VAT and EAT) 
on heart remodelling [7, 25]. The influence is related to 
a direct paracrine effect of EAT, the thickness of which 
correlates with visceral adiposity, as well as the endo-
crine and proinflammatory activity of VAT [10–12, 26]. 
The results of this study have some limitations. Firstly, 
our study group consisted of inpatients from one medical 
center and was relatively small. Secondly, our study had 
a cross-sectional design, so we were unable to observe 
AF occurrence over a long period of time among patients 
whose body composition had been determined previously. 
Conclusions 
The values of echocardiographic parameters are only 
slightly associated with patients’ nutritional status and 
abdominal adiposity and these relationships become 
weaker after adjustment for body surface area. The risk 
of AF occurrence was slightly more strongly or equally 
predicted using unitary values of echocardiographic pa-
rameters than through parameters of body composition, 
however, the use of cut-off values for echocardiographic 
parameters importantly increased their predictive power 
in comparison to parameters of abdominal adiposity.  
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